Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Mayr Charles M Create: Alert

All | News | Filings
Date FiledTypeDescription
03/09/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
07/03/2014 4 Mayr Charles M (Chief Communic Officer) has filed a Form 4 on Actavis plc
Txns: Granted 10,087 options to buy @ $0
Granted 9,180 options to buy @ $224, valued at $2.1M
05/13/2014 4 Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis plc
Txns: Granted 1,692 shares @ $197.05, valued at $333.4k
11/27/2013 4 Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis plc
Txns: Sold 10,000 shares @ $162.6, valued at $1.6M
10/03/2013 4 Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis plc
Txns: Granted 21,396 shares @ $0
10/03/2013 3 Mayr Charles M (Chief Communic Off-Global) has filed a Form 3 on Actavis plc
10/02/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
08/14/2013 4 Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis, Inc.
Txns: Sold 4,820 shares @ $133.2295, valued at $642.2k
03/14/2013 4 Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis, Inc.
Txns: Sold 1,000 shares @ $91.77, valued at $91.8k
03/08/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/05/2013 4 Mayr Charles M (Chief Communic Off-Global) has filed a Form 4 on Actavis, Inc.
Txns: Paid exercise price by delivering 1,880 shares @ $85.54, valued at $160.8k
03/12/2012 4 Mayr Charles M (Sr VP,Corporate Affairs) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Granted 5,199 shares @ $0
Granted 4,276 shares @ $0
02/28/2012 4 Mayr Charles M (Sr VP,Corporate Affairs) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 478 shares @ $58.17, valued at $27.8k
09/23/2011 4 Mayr Charles M (Sr VP,Corporate Affairs) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 632 shares @ $70.04, valued at $44.3k
02/26/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
09/22/2009 4 Mayr Charles M (Sr VP,Corp.Com & Inv.Relations) has filed a Form 4 on WATSON PHARMACEUTICALS INC
09/22/2009 3 Mayr Charles M (Sr VP,Corp.Com & Inv.Relations) has filed a Form 3 on WATSON PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy